Medical Information
Afrique
 

This medical information website is intended only for healthcare professionals in Africa. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

This medicinal product may not have a marketing authorization in your country, may have been allocated via COVAX or may have an authorization for Emergency Use only as granted by the the relevant national health regulatory authority. It is used for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals within the authorized age range. Please refer to the enclosed COVID-19 mRNA Vaccine (BNT162b2) product information (via the link or enclosed) for important treatment considerations regarding the vaccine. This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

COVID-19 mRNA vaccine (BNT162)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

COVID-19 mRNA vaccine (BNT162) Quick Finder

No information available.
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.